Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Mersana Therapeutics (MRSN) Insider Trading & Ownership

Mersana Therapeutics logo

Mersana Therapeutics (NASDAQ:MRSN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$15.47K
Get MRSN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mersana Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MRSN Insider Buying and Selling by Quarter

Mersana Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/27/2025
Mohan Bala
SVP
Sell77$9.90$762.30  
9/12/2025
Martin H Jr. Huber
CEO
Sell2,012$7.31$14,707.72  
(Data available from 1/1/2013 forward)

MRSN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Mersana Therapeutics includes Alejandra Carvajal, Anna Protopapas, Ashish Mandelia, Brian Deschuytner, Martin H Jr. Huber, Mohan Bala, Timothy B Lowinger, and Tushar Misra. Learn more on insiders at MRSN.

13.00% of Mersana Therapeutics stock is owned by insiders. Learn more on MRSN's insider holdings.

The following insiders have sold MRSN shares in the last 24 months: Alejandra Carvajal ($10,927.00), Anna Protopapas ($12,609.00), Ashish Mandelia ($12,419.00), Brian Deschuytner ($16,150.00), Martin H Jr. Huber ($106,021.72), Mohan Bala ($4,324.80), and Timothy B Lowinger ($6,948.00).

Insiders have sold a total of 6,548 Mersana Therapeutics shares in the last 24 months for a total of $169,399.52 sold.



This page (NASDAQ:MRSN) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners